December 1, 2015
Recommended Topic Related To:


"Oct. 29, 2012 -- The FDA has approved Teva's Synribo (omacetaxine mepesuccinate) for treating adults with chronic myelogenous leukemia (CML).

The fast-track approval is for people for whom at least two of the most common treatments ha"...

Tasigna Capsules



Overdose with nilotinib has been reported, where an unspecified number of Tasigna capsules were ingested in combination with alcohol and other drugs. Events included neutropenia, vomiting, and drowsiness. In the event of overdose, the patient should be observed and appropriate supportive treatment given.


Do not use in patients with hypokalemia, hypomagnesemia, or long QT syndrome [see BOXED WARNING].

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 11/30/2015


Tasigna Capsules - User Reviews

Tasigna Capsules User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Tasigna Capsules sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.